Published in J Immunol on August 01, 1974
Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med (1989) 2.32
Schwann cell remyelination and recurrent demyelination in the central nervous system of mice infected with attenuated Theiler's virus. Am J Pathol (1980) 1.12
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curr Top Med Chem (2005) 1.09
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. J Clin Invest (1989) 1.03
The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology (1990) 1.03
The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors. Clin Exp Immunol (1979) 0.95
Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am J Pathol (1997) 0.93
Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Am J Pathol (1999) 0.91
Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J Clin Invest (1992) 0.88
The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide. Immunology (1990) 0.86
Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE). Acta Neuropathol (1985) 0.80
The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A. Acta Neuropathol (1990) 0.80
Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem. Trans Am Clin Climatol Assoc (1978) 0.79
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice. ACS Chem Neurosci (2012) 0.79
Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones. J Exp Med (1991) 0.75
The evidence justifying immunosuppression therapy in multiple sclerosis. Proc R Soc Med (1977) 0.75
Experimental allergic encephalomyelitis. Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks. Am J Pathol (1980) 0.75
Susceptibility to experimental allergic encephalomyelitis in two strains of rats and their hybrids. Acta Neuropathol (1977) 0.75
Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J Immunol (1981) 3.15
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80
Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55
Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50
The Effect of Heparin upon Intra-abdominal Adhesions in Rabbits. Ann Surg (1947) 2.35
Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature (1988) 2.27
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol (1990) 2.07
Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications. Ann N Y Acad Sci (1966) 2.02
Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol (1991) 2.00
Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89
Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest (1981) 1.84
A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med (1991) 1.84
Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents. J Biol Chem (1982) 1.83
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76
Multiple sclerosis (first of two parts). N Engl J Med (1982) 1.72
Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol (1977) 1.58
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58
Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52
Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. J Immunol (1969) 1.51
Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50
Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43
Immunoglobulin A production in ataxia telangiectasia. Science (1965) 1.41
Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol (1992) 1.40
An unusual form of diabetes mellitus in ataxia telangiectasia. N Engl J Med (1970) 1.38
Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest (1968) 1.38
Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J Immunol (1983) 1.35
The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol (1989) 1.32
Antibody affinity and valence in viral neutralization. J Immunol (1972) 1.31
Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature (1981) 1.30
Contact sensitivity in the pig. Immunology (1973) 1.30
Immunological studies in tropical spastic paraparesis. Ann Neurol (1990) 1.26
Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia (1993) 1.25
Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest (1980) 1.24
Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides. Science (1973) 1.21
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20
Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol (1983) 1.20
Lymph node function and lymphocyte circulation in the pig. Adv Exp Med Biol (1973) 1.20
Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol (1990) 1.18
Thymic epithelial cell contains acetylcholine receptor. Lancet (1977) 1.18
Multiple sclerosis (second of two parts). N Engl J Med (1982) 1.18
Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest (1984) 1.17
Basis of microheterogeneity of myelin basic protein. J Biol Chem (1976) 1.17
Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins. J Exp Med (1977) 1.15
Differences between the two myelin basic proteins of the rat central nervous system. A deletion in the smaller protein. Biochim Biophys Acta (1972) 1.15
Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. J Immunol (1993) 1.15
Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann Neurol (1988) 1.14
Presentation of myelin basic protein by murine cerebral vascular endothelial cells. J Immunol (1985) 1.11
Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest (1982) 1.11
The major site of guinea-pig myelin basic protein encephalitogenic in Lewis rats. J Neurochem (1977) 1.11
Scrapie in immunologically deficient mice. Nature (1971) 1.10
Encephalitogenic protein: structure. Science (1969) 1.09
The immune response against myelin basic protein in two strains of rat with different genetic capacity to develop experimental allergic encephalomyelitis. J Exp Med (1975) 1.09
Human cellular immune response to measles virus polypeptides. J Virol (1984) 1.07
Purification of measles virus with preservation of infectivity and antigenicity. J Gen Virol (1979) 1.06
Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis. Ann Neurol (1979) 1.06
Astrocytes: auxiliary cells for immune responses in the central nervous system? Immunol Today (1990) 1.05
Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol (1982) 1.05
Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet (1992) 1.05
Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun (1981) 1.04
Does myasthenic serum bind to the neuromuscular junction? Ann N Y Acad Sci (1966) 1.03
Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol (1993) 1.02
Evaluation of the structural proteins of the hamster neurotropic strain of measles virus with monoclonal antibodies. J Neuroimmunol (1986) 1.01
The immune response of Lewis rats to peptide 68-88 of guinea pig myelin basic protein. I. T cell determinants. J Immunol (1979) 1.01
Systemic histiocytosis presenting as multiple sclerosis. Ann Neurol (1993) 1.01
Monospecific antibody to the haemagglutinin of measles virus. J Gen Virol (1980) 1.00
The response of human lymphocyte subpopulations to measles, mumps, and vaccinia viral antigens. J Immunol (1980) 0.99
HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol (1992) 0.99
A preliminary trial of poly(I,C)-LC in multiple sclerosis. J Biol Response Mod (1985) 0.99
Biosynthesis of measles virus hemagglutinin in persistently infected cells. Arch Virol (1983) 0.99
Quantitation of IgG, IgA and IgM in the CSF by radioimmunoassay. Neurology (1978) 0.98
Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE. Clin Exp Immunol (1980) 0.98
Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell Immunol (1986) 0.98
Isolation and properties of an encephalitogenic protein from bovine, rabbit, and human central nervous system tissue. J Biol Chem (1968) 0.97
Basic protein in brain myelin is phosphorylated by endogenous phospholipid-sensitive Ca2+-dependent protein kinase. J Neurochem (1982) 0.96
Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J Immunol (1986) 0.96
Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology (1992) 0.94
Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J Neuroimmunol (1993) 0.94
Measles virus-polypeptide specificity of the cytotoxic T-lymphocyte response in multiple sclerosis. J Neuroimmunol (1989) 0.92
Central-nervous-system lesions detected by magnetic resonance imaging in an HTLV-1 antibody positive symptomless individual. Lancet (1987) 0.92
Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2. J Neuroimmunol (1993) 0.92
Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination. J Neuroimmunol (1994) 0.92
Antigenic determinants of bovine myelin encephalitogenic protein recognized by rabbit antibody to myelin encephalitogenic protein. J Biol Chem (1975) 0.91
Muscle lesions in myasthenia gravis. Discussion. Ann N Y Acad Sci (1966) 0.91
Influence of ethanol consumption on natural killer cell activity in mice. Alcohol Clin Exp Res (1989) 0.91
Encephalitogenic epitopes of myelin basic protein. Chem Immunol (1989) 0.91
Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus. Infect Immun (1981) 0.90
Cloned measles virus-specific T lymphocytes from a twin with multiple sclerosis. Proc Natl Acad Sci U S A (1983) 0.90
Oligoclonal bands in CSF: twins with MS. Neurology (1984) 0.90
Use of interferon in multiple sclerosis. Ann Neurol (1985) 0.90
Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope. J Immunol (1989) 0.89
Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis. J Virol (1988) 0.89
Immunology of multiple sclerosis. Ann Allergy (1990) 0.89
Lectin receptors in central nervous system myelin. J Neurochem (1980) 0.89